NEU 0.00% $19.97 neuren pharmaceuticals limited

agreed mate, the fact is an acquirer will always try to pay as...

  1. 865 Posts.
    lightbulb Created with Sketch. 376
    agreed mate, the fact is an acquirer will always try to pay as little as possible to realise any synergies and value in the purchase.

    why would someone pay $100M for something if they only expect it to generate an NPV of $100M? It’s a completely fruitless exercise and waste of time and money.

    even if all the phase 2s of 2591 are positive, I don’t see any big pharma coughing up billions upon billions to acquire NEU. The market cap is around $2.5bn now, say for arguments sake it gets to $3.5bn with all the phase 2s in the bag, you might only get a 50-70% premium on that.


 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.97
Change
0.000(0.00%)
Mkt cap ! $2.552B
Open High Low Value Volume
$19.96 $19.97 $19.69 $4.156M 209.6K

Buyers (Bids)

No. Vol. Price($)
1 246 $19.88
 

Sellers (Offers)

Price($) Vol. No.
$19.99 512 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.